Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
PharmaTimes Media Limited – kickstarting healthcare conversations.
News
FDA approves Tivicay pd for youngest HIV patients
New treatment option expands paediatric HIV care access
Read more
Report
Connected trials
Clinical trials are becoming increasingly complex. In a 2023 survey, 70% of investigative site staff said conducting studies had become more difficult over the previous five years. For sponsors, this shows up as delayed decisions, duplicated effort and re
Read more
Report
Koala trial doses first patient with novel KMA-targeting CAR-T
Australian teams advance first-in-human multiple myeloma therapy
Read more
Report
Heparegenix wins orphan drug status for darizmetinib
Designation supports development for post-hepatectomy liver failure
Read more
Report
IMAVVY approved as first targeted therapy for wAIHA
New treatment reduces pathogenic IgG while preserving B-cell function
Read more
Report
Pro access
Upgrade to see all 13 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.